Enhancer of Zeste Homolog 2 inhibitors

  • US 10,478,426 B2
  • Filed: 03/20/2018
  • Issued: 11/19/2019
  • Est. Priority Date: 05/16/2012
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a hematologic cancer comprising administering to a patient with cancer a therapeutically effective amount of a compound of formula (I):

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×